StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex operating margin

Operating margin is operating income as a percentage of revenue.

Vaccinex's operating margin for the twelve months ending Dec 31, 2024 was -3117.3%. For fiscal 2024 it was -3117.3%, against -4014.9% the year before. The highest annual figure on record is -2498.9% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-3117.3%+897.6
FY2023Dec 31, 2023-4014.9%+3223.6
FY2022Dec 31, 2022-7238.5%−4739.7
FY2021Dec 31, 2021-2498.9%+2034.1
FY2020Dec 31, 2020-4533.0%+1588.5
FY2019Dec 31, 2019-6121.4%−2353.3
FY2018Dec 31, 2018-3768.1%+19680.8
FY2017Dec 31, 2017-23448.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2024Dec 31, 2024-1590.1%+27579.9
Q3 FY2024Sep 30, 2024-8753.8%−7847.3
Q2 FY2024Jun 30, 2024-2466.4%−191.3
Q1 FY2024Mar 31, 2024-4878.8%+4705.2
Q3 FY2023Sep 30, 2023-29170.0%−19044.0
Q1 FY2023Mar 31, 2023-906.5%−172.4
Q4 FY2022Dec 31, 2022-2275.1%−901.8
Q3 FY2022Sep 30, 2022-9584.0%−7683.5
Q3 FY2021Sep 30, 2021-10126.0%+25306.0
Q1 FY2021Mar 31, 2021-734.1%+8989.3
Q3 FY2020Sep 30, 2020-1373.3%+3039.6
Q3 FY2019Sep 30, 2019-1900.5%+1359.1
Q2 FY2019Jun 30, 2019-35432.0%−30228.0
Q1 FY2019Mar 31, 2019-9723.4%−6952.0
Q4 FY2018Dec 31, 2018-4412.9%–
Q3 FY2018Sep 30, 2018-3259.6%–
Q2 FY2018Jun 30, 2018-5204.0%–
Q1 FY2018Mar 31, 2018-2771.4%–

More Vaccinex figures

See a number that looks wrong?